(Q36476471)

English

Integrating comparative effectiveness design elements and endpoints into a phase III, randomized clinical trial (SWOG S1007) evaluating oncotypeDX-guided management for women with breast cancer involving lymph nodes

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Integrating comparative effectiveness design elements and endpoints into a phase III, randomized clinical trial (SWOG S1007) evaluating oncotypeDX-guided management for women with breast cancer involving lymph nodes (English)

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

phase III clinical trial

0 references

0 references

Ana Maria Gonzalez-Angulo

3

object named as

Ana M Gonzalez-Angulo

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

David L Veenstra

8

object named as

David Veenstra

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Gabriel N Hortobagyi

9

object named as

Gabriel N Hortobagyi

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

4

object named as

Sean Tunis

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

author name string

Scott D Ramsey

1

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

William E Barlow

2

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Laurence Baker

5

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

John Crowley

6

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Patricia Deverka

7

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

language of work or name

0 references

publication date

18 September 2012

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Contemporary Clinical Trials

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

34

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

1

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

1-9

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

The value of comparative effectiveness research: projected return on investment of the RxPONDER trial (SWOG S1007)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3525786

30 September 2017

Stakeholder participation in comparative effectiveness research: defining a framework for effective engagement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3525786

30 September 2017

Economic evaluation of genomic test-directed chemotherapy for early-stage lymph node-positive breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3525786

30 September 2017

Risk of Recurrence and Chemotherapy Benefit for Patients With Node-Negative, Estrogen Receptor–Positive Breast Cancer: Recurrence Score Alone and Integrated With Pathologic and Clinical Factors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3525786

30 September 2017

The value of value of information: best informing research design and prioritization using current methods.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3525786

30 September 2017

Comparative effectiveness research: Policy context, methods development and research infrastructure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3525786

30 September 2017

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3525786

30 September 2017

Value of information analyses of economic randomized controlled trials: the treatment of intermittent claudication

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3525786

30 September 2017

Optimal clinical trial design using value of information methods with imperfect implementation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3525786

30 September 2017

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3525786

30 September 2017

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3525786

30 September 2017

Randomized phase III clinical trial designs for targeted agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3525786

28 June 2018

How Best To Engage Patients, Doctors, And Other Stakeholders In Designing Comparative Effectiveness Studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3525786

21 September 2018

Comparative effectiveness research: a report from the Institute of Medicine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3525786

21 September 2018

Anatomy and Biology: Two Complementary Sides of Breast Cancer Prognostication

1 reference

https://pubmed.ncbi.nlm.nih.gov/23000081

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system

1 reference

https://pubmed.ncbi.nlm.nih.gov/23000081

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An economic approach to clinical trial design and research priority-setting

1 reference

https://pubmed.ncbi.nlm.nih.gov/23000081

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.CCT.2012.09.003

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36476471&oldid=1883656135"